APA (7th ed.) Citation

Seery, T., Sender, L., Jafari, O., Jones, F., Spilman, P., Reddy, S. B., & Soon-Shiong, P. Case report: PD-L1-targeted high-affinity natural killer cells and IL-15 superagonist N-803-based therapy extend overall survival of advanced metastatic pancreatic cancer patients. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Seery, Tara, Lennie Sender, Omid Jafari, Frank Jones, Patricia Spilman, Sandeep B. Reddy, and Patrick Soon-Shiong. Case Report: PD-L1-targeted High-affinity Natural Killer Cells and IL-15 Superagonist N-803-based Therapy Extend Overall Survival of Advanced Metastatic Pancreatic Cancer Patients. Frontiers Media S.A.

MLA (9th ed.) Citation

Seery, Tara, et al. Case Report: PD-L1-targeted High-affinity Natural Killer Cells and IL-15 Superagonist N-803-based Therapy Extend Overall Survival of Advanced Metastatic Pancreatic Cancer Patients. Frontiers Media S.A.